header-20.jpg
Translational Research

Targeting the Dysregulation of Adiponectin as a Novel Prostate Cancer Therapy

Targeting the dysregulation of adipokine hormone adiponectin in advanced prostate cancer to improve therapeutic strategies for advanced disease

Investigators

 

Dr Jennifer Gunter APCRC-Q, IHBI, QUT, TRI
Dr Lisa Philp APCRC-Q, IHBI, QUT, TRI
Professor Colleen Nelson APCRC-Q, IHBI, QUT, TRI
Dr Henry Hsu

Duration

2020 - 2023

Funding

United States Department of Defense Prostate Cancer Research Program
(Idea Development Award)		 $1,271,331